| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 29,262 | 32,148 | 21,258 | 16,471 | | Cost of Revenue | (28,298) | 17,996 | 26,154 | 10,146 | | | Gross Profit | 57,560 | 14,152 | (4,896) | 6,325 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (1,251) | 1,955 | (88) | 3,684 | | Non Recurring | 34,825 |
-
|
-
|
-
| | Others | 4,413 | 5,622 | 5,654 | 2,730 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 19,573 | 6,575 | (10,462) | (89) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (885) | 835 | 851 | 464 | | Earnings Before Interest And Taxes | 18,688 | 7,410 | (9,611) | 375 | | Interest Expense | 309 | 126 | 15 | (242) | | Income Before Tax | 18,379 | 7,284 | (9,626) | 617 | | Income Tax Expense | 13,301 | 7,323 | 2,379 | 7,771 | | Minority Interest | (3,147) |
-
|
-
| (297) | | | | Net Income From Continuing Ops | 1,931 | (39) | (12,005) | (7,451) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,931 | (39) | (12,005) | (7,451) | | Preferred Stock And Other Adjustments | 2,256 | (1,642) | (614) |
-
| | | Net Income Applicable To Common Shares | $4,187 | ($1,681) | ($12,619) | ($7,451) |
|
0.02% Nasdaq 
0.33%
Income Statement
